Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interplay between PNPLA3 genotype, liver steatosis, and cardiac remodeling in young adults: A magnetic resonance imaging study. | Physiol Rep | 2026 | 42568180 | PubTator, text mining | PubMed |
| Ambient fine particulate matter components and liver fat and stiffness in youth: metabolic vulnerability in PNPLA3 risk carriers. | Environ Int | 2026 | 42561592 | PubTator, text mining | PubMed |
| Rethinking the hepatoprotective potential of vegetarian diets in dysfunction-associated steatotic liver disease/metabolic-associated fatty liver disease: a critical narrative review. | Front Nutr | 2026 | 42529254 | PubTator, text mining | PubMed |
| Autophagy in MASLD: A Metabolic and Precision Medicine Perspective. | Liver Int | 2026 | 42522599 | PubTator, text mining | PubMed |
| Genome-Wide Association Studies in Hepatocellular Carcinoma: Aetiology-Specific Susceptibility, Functional Interpretation, and Clinical Translation. | Genes (Basel) | 2026 | 42510799 | PubTator, text mining | PubMed |
| Molecular analysis of genes MICA, GPC3, PNPLA3, and TM6SF2 polymorphisms in patients of hepatocellular carcinoma. | Nucleosides Nucleotides Nucleic Acids | 2026 | 42495938 | PubTator, text mining | PubMed |
| Association between the PNPLA3 I148M (rs738409) polymorphism and risk of metabolic dysfunction-associated steatotic liver disease: a meta-analysis (2015-2025). | BMC Gastroenterol | 2026 | 42481975 | PubTator, text mining | PubMed |
| Targeting PNPLA3 I148M variant in MASLD: Cell-type specific mechanisms and precision therapy opportunities. | Biomed Pharmacother | 2026 | 42480153 | PubTator, text mining | PubMed |
| Cryptogenic steatotic liver disease: a lean phenotype associated with increased liver-related mortality. | Gut | 2026 | 42463421 | PubTator, text mining | PubMed |
| Correction to 'Fifteen Years of PNPLA3: Transforming Hepatology through Human Genetics'. | Liver Int | 2026 | 42454759 | PubTator, text mining | PubMed |
| Genetic variants associated with triglyceride metabolism and fasting triglyceride concentrations: a systematic review and a meta-analysis. | J Clin Lipidol | 2026 | 42448503 | PubTator, text mining | PubMed |
| Comparative effectiveness of subcutaneous GLP-1 receptor agonists versus SGLT2 inhibitors on metabolic and hepatic outcomes in T2DM with MASLD: a propensity score-matched study. | J Endocrinol Invest | 2026 | 42440238 | PubTator, text mining | PubMed |
| Prime editing enables isogenic modeling of PNPLA3-I148M-associated lipotoxicity in hepatocytes. | Mol Ther Nucleic Acids | 2026 | 42438834 | PubTator, text mining | PubMed |
| Genome-wide association and polygenic risk score analyses of MASLD-related hepatic steatosis severity in a Taiwanese Han population. | Cell Biosci | 2026 | 42432750 | PubTator, text mining | PubMed |
| PNPLA3 I148M Variant Activates Hepatic Stellate Cells via AMIGO2 Upregulation Using iPSC-Derived Model. | Liver Int | 2026 | 42394201 | PubTator, text mining | PubMed |
| Genetic Impacts on Variability of Body Fat Distribution Uncover Gene-Environment and Gene-Gene Interactions. | bioRxiv | 2026 | 42388805 | PubTator, text mining | PubMed |
| Reply to: "Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3". | J Hepatol | 2026 | 42379313 | PubTator, text mining | PubMed |
| Patatin-like phosphatase domain-containing 3 genotype and quality of dietary fat modify the liver adiposity in men. | Eur J Nutr | 2026 | 42371130 | PubTator, text mining | PubMed |
| Genetic and genomic insights across the steatotic liver disease spectrum. | Clin Mol Hepatol | 2026 | 42366560 | PubTator, text mining | PubMed |
| Programmable Double Peptide Nucleic Acid-Locked Nucleic Acid Molecular Switch Enables Extraction-Free Direct Zygosity Discrimination of Single Nucleotide Polymorphisms. | Anal Chem | 2026 | 42324653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=2